The clinical observation of banazapril accompanied with metoprolol for treatment of congestive heart failure
HE Jingxian
Abstract
HE Jingxian
Abstract
Objective:To evaluate the clinical therapeutic efficacy of banazapril accompanied with metoprolol for treatment of congestive heart failure (CHF).Methods:80 cases wit congestive heart failure were divided into two groups.The patient of control group received routine treatment (Digitalis and diuretics).The obserevation groups were given banazapril and metoprolol beside routine treatment.Results:There were more significant improvement in NYHA functional class in banazapril accompanied With metoprolol group than in placeebo groub.Banazapril and metoprolol were associated with greater overall reduction of left ventricular end-diastolic diameter and an overall increase in the LVEF%.Conclusion:Addition of banazapril and metoprolol to standard therapy may profoundly improve cardiac function and prevent clinical deterioration in patients with CHF when compared with patients without banazapril and metoprolol treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the clinical therapeutic efficacy of banazapril accompanied with metoprolol for treatment of congestive heart failure (CHF).Methods:80 cases wit congestive heart failure were divided into two groups.The patient of control group received routine treatment (Digitalis and diuretics).The obserevation groups were given banazapril and metoprolol beside routine treatment.Results:There were more significant improvement in NYHA functional class in banazapril accompanied With metoprolol group than in placeebo groub.Banazapril and metoprolol were associated with greater overall reduction of left ventricular end-diastolic diameter and an overall increase in the LVEF%.Conclusion:Addition of banazapril and metoprolol to standard therapy may profoundly improve cardiac function and prevent clinical deterioration in patients with CHF when compared with patients without banazapril and metoprolol treatment.
Key concepts: Metoprolol, Medicine, Heart failure, Cardiology, Digitalis, Ejection fraction, Internal medicine, Digoxin